M
Massimiliano Raponi
Researcher at Boston Children's Hospital
Publications - 134
Citations - 2268
Massimiliano Raponi is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 22, co-authored 104 publications receiving 1402 citations.
Papers
More filters
Journal ArticleDOI
Nonalcoholic Fatty Liver Disease: A Challenge for Pediatricians
Valerio Nobili,Naim Alkhouri,Anna Alisi,Claudia Della Corte,Emer Fitzpatrick,Massimiliano Raponi,Anil Dhawan +6 more
TL;DR: The mainstay of treatment for NAFLD remains lifestyle modifications and weight loss and vitamin E may be considered as a NASH-specific therapy in children, and there are several ongoing human studies evaluating different therapeutic targets forNAFLD.
Journal ArticleDOI
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.
Rita Carsetti,Salvatore Zaffina,Eva Piano Mortari,Sara Terreri,Francesco Corrente,Claudia Capponi,Patrizia Palomba,Mattia Mirabella,Simona Cascioli,Paolo Palange,Ilaria Cuccaro,Cinzia Milito,Alimuddin Zumla,Markus Maeurer,Markus Maeurer,Vincenzo Camisa,Maria Vinci,Annapaola Santoro,Eleonora Cimini,Luisa Marchioni,Emanuele Nicastri,Fabrizio Palmieri,Chiara Agrati,Giuseppe Ippolito,Ottavia Porzio,Ottavia Porzio,Carlo Concato,Andrea Onetti Muda,Massimiliano Raponi,Concetta Quintarelli,Concetta Quintarelli,Isabella Quinti,Franco Locatelli,Franco Locatelli +33 more
TL;DR: In this article, the authors performed a longitudinal follow-up, flow-cytometric and serological analysis of innate and adaptive immunity in 64 adults with a spectrum of clinical presentations.
Journal ArticleDOI
Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach
TL;DR: An overview of current concepts in epidemiology, histological features, etiopathogenesis, diagnosis and treatment of NAFLD in children and adolescents is provided.
Journal ArticleDOI
Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial.
Claudia Della Corte,Guido Carpino,Rita De Vito,Cristiano De Stefanis,Anna Alisi,Stefano Cianfarani,Diletta Overi,Antonella Mosca,Laura Stronati,Salvatore Cucchiara,Massimiliano Raponi,Eugenio Gaudio,Christopher D. Byrne,Christopher D. Byrne,Valerio Nobili +14 more
TL;DR: DHA plus vitamin D treatment improved insulin-resistance, lipid profile, ALT and NAS, in obese children with biopsy-proven NAFLD and vitamin D deficiency in a randomized, double blind placebo-controlled trial.
Journal ArticleDOI
Pediatric non-alcoholic fatty liver disease: Preventive and therapeutic value of lifestyle intervention
TL;DR: The clinical course, pathogenesis and management of NAFLD in children, highlighting the preventive and therapeutic value of lifestyle intervention.